Halozyme to Report Third Quarter 2025 Financial and Operating Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced it will release its third quarter 2025 financial and operating results on Monday, November 3, 2025, following the close of trading. Halozyme will host a conference call on Monday, November 3, 2025 at 1:30 p.m. PT/4:30 p.m. ET to discuss the results. The conference call may be […]